Suppr超能文献

种族/族裔决定接受手术治疗的T1aN0M0期肾细胞癌患者的预期寿命。

Race/Ethnicity Determines Life Expectancy in Surgically Treated T1aN0M0 Renal Cell Carcinoma Patients.

作者信息

Würnschimmel Christoph, Collà Ruvolo Claudia, Nocera Luigi, Wenzel Mike, Tian Zhe, Saad Fred, Briganti Alberto, Shariat Shahrokh F, Mirone Vincenzo, Chun Felix K H, Tilki Derya, Graefen Markus, Karakiewicz Pierre I

机构信息

Martini-Klinik Prostate Cancer Center, University Hospital Hamburg-Eppendorf, Hamburg, Germany; Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada.

Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada; Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples Federico II, Naples, Italy.

出版信息

Eur Urol Focus. 2022 Jan;8(1):191-199. doi: 10.1016/j.euf.2021.02.004. Epub 2021 Feb 18.

Abstract

BACKGROUND

Life expectancy (LE) is an important consideration in the clinical decision-making for T1aN0M0 renal cell cancer (RCC) patients.

OBJECTIVE

To test the effect of race/ethnicity (Caucasian, African American, Hispanic/Latino, and Asian) on LE predictions from Social Security Administration (SSA) life tables in male and female T1aN0M0 RCC patients.

DESIGN, SETTING, AND PARTICIPANTS: We relied on the Surveillance, Epidemiology, and End Results database.

INTERVENTION

Radical nephrectomy (RN) and partial nephrectomy (PN).

OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS

Five-year and 10-yr observed overall survival (OS) of pT1aN0M0 RCC patients treated between 2004 and 2006 were compared with the LE predicted from SSA life tables. We repeated the comparison in a more contemporary cohort (2009-2011), with 5-yr follow-up and higher PN rates.

RESULTS AND LIMITATIONS

In the 2004-2006 cohort, PN rate was 40.7%. OS followed the predicted LE in Caucasians, Hispanics/Latinos, and Asians, but not in African Americans, in whom 5-yr OS rates were 5.0% (male) and 8.7% (female) and 10-yr rates were 4.2% (male) and 11.1% (female) lower than predicted. In the 2009-2011 cohort, PN rate was 59.4%. Same observations were made for OS versus predicted LE in Caucasians, Hispanics/Latinos, and Asians. In African Americans, 5-yr OS rates were 1.5% (male) and 4.9% (female) lower than predicted.

CONCLUSIONS

In RN- or PN-treated pT1aN0M0 RCC patients, LE predictions closely approximated OS of Caucasians, Hispanics/Latinos, and Asians. In African-American patients, SSA life tables overestimated LE, more in females than in males. The limitations of our study are its retrospective nature, its validity for US patients only, and the under-representation of racial/ethnic minorities.

PATIENT SUMMARY

Social Security Administration life tables can be used to estimate long-term life expectancy in patients who are surgically treated for renal cancer (≤4 cm). However, while for Caucasians, Hispanics/Latinos, and Asians, the prediction performs well, life expectancy of African Americans is generally overestimated by life table predictions. TAKE  HOME MESSAGE: In the clinical decision-making process for T1aN0M0 renal cell cancer patients eligible for radical or partial nephrectomy, the important influence of patient sex and race/ethnicity on life expectancy should be taken into account, when using Social Security Administration life tables.

摘要

背景

预期寿命(LE)是T1aN0M0肾细胞癌(RCC)患者临床决策中的一个重要考量因素。

目的

检验种族/族裔(白种人、非裔美国人、西班牙裔/拉丁裔和亚裔)对社会保障管理局(SSA)生命表预测男性和女性T1aN0M0 RCC患者预期寿命的影响。

设计、设置和参与者:我们依赖于监测、流行病学和最终结果数据库。

干预

根治性肾切除术(RN)和部分肾切除术(PN)。

结果测量和统计分析

将2004年至2006年接受治疗的pT1aN0M0 RCC患者的5年和10年观察到的总生存率(OS)与SSA生命表预测的预期寿命进行比较。我们在一个更近期的队列(2009 - 2011年)中重复了该比较,该队列有5年随访且部分肾切除术发生率更高。

结果与局限性

在2004 - 2006年队列中,部分肾切除术发生率为40.7%。白种人、西班牙裔/拉丁裔和亚裔的总生存率遵循预测的预期寿命,但非裔美国人并非如此,其5年总生存率男性为5.0%,女性为8.7%,10年总生存率男性为4.2%,女性为11.1%,低于预测值。在2009 - 2011年队列中,部分肾切除术发生率为59.4%。对于白种人、西班牙裔/拉丁裔和亚裔,总生存率与预测的预期寿命的观察结果相同。在非裔美国人中,5年总生存率男性比预测值低1.5%,女性比预测值低4.9%。

结论

在接受根治性肾切除术或部分肾切除术治疗的pT1aN0M0 RCC患者中,预期寿命预测与白种人、西班牙裔/拉丁裔和亚裔的总生存率密切接近。在非裔美国患者中,SSA生命表高估了预期寿命,女性比男性更明显。我们研究的局限性在于其回顾性性质、仅对美国患者有效以及种族/族裔少数群体代表性不足。

患者总结

社会保障管理局生命表可用于估计接受肾癌手术治疗(≤4厘米)患者的长期预期寿命。然而,虽然对于白种人、西班牙裔/拉丁裔和亚裔,该预测效果良好,但生命表预测通常高估了非裔美国人的预期寿命。要点:在对适合根治性或部分肾切除术的T1aN0M0肾细胞癌患者进行临床决策过程中,使用社会保障管理局生命表时应考虑患者性别和种族/族裔对预期寿命的重要影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验